Addiction to topically used cyclopentolate hydrochloride: A case report

dc.contributor.buuauthorAkkaya, Cengiz
dc.contributor.buuauthorZorlu Kocagoz, Sevilay
dc.contributor.buuauthorSarandöl, Aslı
dc.contributor.buuauthorEker, Salih Saygın
dc.contributor.buuauthorKırlı, Selçuk
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı.tr_TR
dc.contributor.researcherid
dc.contributor.scopusid14061855100tr_TR
dc.contributor.scopusid24492525800tr_TR
dc.contributor.scopusid14020405100tr_TR
dc.contributor.scopusid14019347700tr_TR
dc.contributor.scopusid14019745700tr_TR
dc.date.accessioned2024-03-20T11:59:17Z
dc.date.available2024-03-20T11:59:17Z
dc.date.issued2008-10-01
dc.description.abstract
dc.identifier.citationAkkaya, C. vd. (2008). "Addiction to topically used cyclopentolate hydrochloride: A case report". Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(7), 1752-1753en_US
dc.identifier.endpage1753tr_TR
dc.identifier.issn0278-5846
dc.identifier.issn1878-4216
dc.identifier.issue7tr_TR
dc.identifier.pubmed18674584tr_TR
dc.identifier.scopus2-s2.0-51349152656tr_TR
dc.identifier.startpage1752tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.pnpbp.2008.07.003en_US
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0278584608002017en_US
dc.identifier.urihttps://hdl.handle.net/11452/40526en_US
dc.identifier.volume32tr_TR
dc.identifier.wos000259843500025tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.journalProgress in Neuro-Psychopharmacology and Biological Psychiatryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectNeurosciences & neurologyen_US
dc.subjectPsychiatryen_US
dc.subjectPharmacology & pharmacyen_US
dc.subjectAbuseen_US
dc.subject.emtreeCarbamazepineen_US
dc.subject.emtreeCholinergic receptor blocking agenten_US
dc.subject.emtreeCyclopentolateen_US
dc.subject.emtreeDexamethasoneen_US
dc.subject.emtreeEscitalopramen_US
dc.subject.emtreeFluoxetineen_US
dc.subject.emtreeMethylprednisoloneen_US
dc.subject.emtreePimozideen_US
dc.subject.emtreeRisperidoneen_US
dc.subject.emtreeSertralineen_US
dc.subject.emtreeAddictionen_US
dc.subject.emtreeAdulten_US
dc.subject.emtreeAlcohol abuseen_US
dc.subject.emtreeBehcet diseaseen_US
dc.subject.emtreeCase reporten_US
dc.subject.emtreeDepressionen_US
dc.subject.emtreeDrug dose escalationen_US
dc.subject.emtreeDrug substitutionen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeLetteren_US
dc.subject.emtreeMajor depressionen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreePatient complianceen_US
dc.subject.emtreeUveitisen_US
dc.subject.emtreeVisual impairmenten_US
dc.subject.meshAdulten_US
dc.subject.meshCyclopentolateen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMuscarinic antagonistsen_US
dc.subject.meshSubstance-related disordersen_US
dc.subject.otherClinical neurologyen_US
dc.subject.scopusCase Report; Tropicamide; Orphenadrineen_US
dc.subject.wosClinical Neurologyen_US
dc.subject.wosNeurosciencesen_US
dc.subject.wosPharmacology & Pharmacyen_US
dc.subject.wosPsychiatryen_US
dc.titleAddiction to topically used cyclopentolate hydrochloride: A case reporten_US
dc.typeLetteren_US
dc.wos.quartileQ2en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections